Skip to content

Growth Hormone and Insulin Growth Factor 1 Deficiencies in Children/Adolescents Following Traumatic Brain Injury: The Impact on Growth and Neuropsychological Development

Growth Hormone and Insulin Growth Factor 1 Deficiencies in Children/Adolescents Following Traumatic Brain Injury: The Impact on Growth and Neuropsychological Recovery

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00929045
Enrollment
8
Registered
2009-06-26
Start date
2007-07-31
Completion date
2010-12-31
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Keywords

Growth Hormone replacement, subject 8 to 21, moderate to severe traumatic brain injury, growth hormone deficient

Brief summary

The purpose of this study is to look at the relationship between growth hormones, and recovery from a TBI - traumatic brain injury. It is believed that a TBI may interfere with the body's ability to produce growth hormones. These hormones may be needed by the body for growth, mental development and sexual maturation.

Interventions

DRUGGrowth Hormone Replacement

Sponsors

Virginia Commonwealth University
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
University of Virginia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* This is Phase II trial-subjects have already completed Phase I. * Traumatic brain injury (TBI). * Results of the blood work from Phase I shows that your growth hormone levels are low.

Exclusion criteria

* Have not completed Phase I of the study.

Design outcomes

Primary

MeasureTime frame
Neurocognitive changes following moderate/severe TBI1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026